Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Kite Pharma, Inc. unveiled a two-year discovery collaboration with license option rights on 3 September with HiFiBiO Therapeutics...